NASDAQ:MNPR | Income Statement | Monopar Therapeutics

Complete source-backed income-statement history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$4.77M$6.64M-$6.64M-$5.31M-$0.628,542,450
2026-03-31$0.00$3.49M$5.23M-$5.23M-$3.89M-$0.468,535,443
2025-12-31$3.94M$6.16M-$6.16M-$5.2M-$0.64374,184
2025-09-30$2.59M$4.09M-$4.09M-$3.44M-$0.487,123,849
2025-06-30$1.73M$3.23M-$3.23M-$2.45M-$0.356,998,082
2025-03-31$1.64M$3.22M-$3.22M-$2.62M-$0.386,987,381
2024-12-31$9.92M$11.07M-$11.07M-$10.93M-$2.75370,881
2024-09-30$984,278.00$1.57M-$1.57M-$1.3M-$0.373,520,398
2024-06-30$1.13M$1.79M-$1.79M-$1.72M-$0.493,502,927
2024-03-31$966,110.00$1.72M-$1.72M-$1.64M-$0.513,195,963
2023-12-31$1.04M$1.91M-$1.91M-$1.81M-$0.6154,434
2023-09-30$1.32M$2.07M-$2.07M-$1.95M-$0.692,823,680
2023-06-30$1.59M$2.33M-$2.33M-$2.2M-$0.1613,420,029
2023-03-31$1.65M$2.53M-$2.53M-$2.43M-$0.1913,105,831
2022-12-31$2.1M$2.91M-$2.91M-$2.9M-$0.2353,779
2022-09-30$1.73M$2.41M-$2.41M-$2.4M-$0.1912,754,685
2022-06-30$2.08M$2.76M-$2.76M-$2.76M-$0.2212,632,381
2022-03-31$1.68M$2.46M-$2.46M-$2.46M12,604,443
2021-12-31$1.98M$2.68M-$2.68M-$2.68M39,899
2021-09-30$1.83M$2.46M-$2.46M-$2.46M12,582,728
2021-06-30$1.48M$2.09M-$2.09M-$2.08M12,569,933
2021-03-31$1.21M$1.89M-$1.89M-$1.88M12,139,422
2020-12-31$1.63M$2.26M-$2.26M-$2.13M165,843
2020-09-30$1.26M$1.65M-$1.65M-$1.64M11,116,409
2020-06-30$832,503.00$1.46M-$1.46M-$1.45M10,648,285
2020-03-31$344,407.00$1.14M-$1.14M-$1.09M10,608,199
2019-12-31$0.00$583,778.00$1.22M-$1.22M-$1.21M29,774
2019-09-30$0.00$219,846.00$759,448.00-$759,448.00-$736,080.009,291,421
2019-06-30$0.00$329,294.00$932,109.00-$932,109.00-$905,700.009,291,421
2019-03-31$0.00$835,600.00$1.41M-$1.41M-$1.38M9,291,421
2018-12-31$0.00$520,982.00$926,358.00-$926,358.00-$890,461.000
2018-09-30$0.00$303,684.00$667,532.00-$667,532.00-$640,184.009,291,421
2018-06-30$0.00$303,684.00$667,532.00-$667,532.00-$640,184.009,291,421
2018-03-31$0.00$457,141.00$897,260.00-$897,260.00-$876,347.009,291,421
2017-12-31$0.00$309,315.00$736,800.00-$736,800.00-$713,583.00171,661
2017-09-30$0.00$180,675.00$14.9M-$14.9M-$14.88M8,870,878
2017-06-30$0.00$311,593.00$594,957.00-$594,957.00-$591,438.008,615,621
2017-03-31$0.00$133,736.00$373,839.00-$373,839.00-$372,915.008,338,783

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$0.00$9.9M$16.7M-$16.7M-$13.72M$800.00-$13.72M-$1.857,411,121
2024-12-31$0.00$13.01M$16.16M-$16.16M-$15.59M$800.00-$15.59M-$4.113,790,202
2023-12-31$5.6M$8.83M-$8.83M-$8.4M$800.00-$8.4M-$3.042,764,790
2022-12-31$7.59M$10.54M-$10.54M$800.00-$10.52M-$0.8312,718,166
2021-12-31$6.49M$9.13M-$9.13M$0.00-$9.1M12,471,21712,472,217
2020-12-31$4.07M$6.51M-$6.51M$18,361.00-$6.3M10,958,256
2019-12-31$0.00$1.97M$4.32M-$4.32M$0.00-$4.22M9,321,195
2018-12-31$0.00$1.77M$3.33M-$3.33M-$3.3M-$70,815.00-$3.23M9,291,421
2017-12-31$0.00$935,319.00$16.6M-$16.6M-$16.55M-$3,558.00-$16.55M8,782,037
2016-12-31$0.00$280,355.00$1.19M-$1.19M$800.00-$1.19M